Study of DLL3-CAR-NK Cells in the Treatment of Extensive Stage Small Cell Lung Cancer
NCT05507593
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
18
Enrollment
OTHER
Sponsor class
Conditions
SCLC, Extensive Stage
Interventions
BIOLOGICAL:
DLL3-CAR-NK cells
Sponsor
Tianjin Medical University Cancer Institute and Hospital